IVC Wealth Advisors’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
IVC Wealth Advisors's BMY Position: Q3 2026 in Review
IVC Wealth Advisors reduced its Bristol-Myers Squibb (BMY) stake by 4.3% in Q3 2026, selling an estimated $14K and leaving 4,979 shares worth $311K. The position accounts for 0.12% of the portfolio, ranked #131.
IVC Wealth Advisors first reported a position in BMY in Q4 2020 and has held it in 23 quarters since. The position peaked at $689K in Q2 2022. 2,559 funds tracked by Wall St. Rank hold BMY as of Q3 2026.
- IVC Wealth Advisors held 4,979 shares of Bristol-Myers Squibb worth $311K as of Q3 2026.
- IVC Wealth Advisors sold 222 Bristol-Myers Squibb shares in Q3 2026, an estimated $14K.
- Bristol-Myers Squibb made up 0.12% of IVC Wealth Advisors's portfolio in Q3 2026, its #131 holding.
- IVC Wealth Advisors first reported a position in Bristol-Myers Squibb in Q4 2020 and has held it in 23 quarters since.
- IVC Wealth Advisors's Bristol-Myers Squibb position peaked at $689K in Q2 2022.
- 2,559 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2026.
Based on IVC Wealth Advisors's 13F filing for Q3 2026, filed 23 Oct 2026.